1 trial result announced this day (US Eastern).
| Time (ET) | Drug / result | Company | Outcome | Before | 24h later | 24h move |
|---|---|---|---|---|---|---|
| 8:30 AM | Envudeucitinib SLE | Alumis (ALMS) | Missed | $21.81 | $10.02 | −54.05% |
For information only. Not investment or medical advice. Prices are historical, from consolidated market data, and may contain errors. Always check the original source.